To evaluate whether whole-body MR has a predictive role before treatment and may asses the response after two courses of chemotherapy in comparison to FDG-PET/C
Since the mid-1990s, F-18-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination ...
The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance im...
Since the mid-1990s, F-18-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination ...
To evaluate whether imaging features of pathologic lymph nodes on whole-body diffusion-weighted MR h...
Computed tomography (CT), 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), and hybrid ...
Malignant lymphoma is the 5th most common tumor type, comprising a large group of cancers with disti...
The lack of validation and standardization represents the main drawback for a clear role of whole-bo...
To prospectively compare patient experience with whole-body MRI and 18F-FDG-PETCT in the initial sta...
The potential of FDG-PET and MRI in monitoring response to treatment in lymphoma is reviewed. Both F...
Introduction: This study prospectively evaluated whole-body magnetic resonance/diffusion-weighted im...
Computed tomography, 18FDG-PET and the hybrid FDGPET/CT are the most commonly used diagnostic tools ...
AIM: To compare the accuracy of whole-body magnetic resonance imaging (Wb-MRI) with diffusion-weig...
Positron emission tomography with 2-deoxy-2-fluoro-D-glucose integrated with computed tomography (FD...
Imaging of lymphoma is based on the use of18F-fluorodeoxyglucose positron emission tomography/comput...
Objectives To compare whole body-MRI (WB-MRI) with diffusion-weighted imaging and FDG-PET/CT in stag...
Since the mid-1990s, F-18-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination ...
The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance im...
Since the mid-1990s, F-18-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination ...
To evaluate whether imaging features of pathologic lymph nodes on whole-body diffusion-weighted MR h...
Computed tomography (CT), 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), and hybrid ...
Malignant lymphoma is the 5th most common tumor type, comprising a large group of cancers with disti...
The lack of validation and standardization represents the main drawback for a clear role of whole-bo...
To prospectively compare patient experience with whole-body MRI and 18F-FDG-PETCT in the initial sta...
The potential of FDG-PET and MRI in monitoring response to treatment in lymphoma is reviewed. Both F...
Introduction: This study prospectively evaluated whole-body magnetic resonance/diffusion-weighted im...
Computed tomography, 18FDG-PET and the hybrid FDGPET/CT are the most commonly used diagnostic tools ...
AIM: To compare the accuracy of whole-body magnetic resonance imaging (Wb-MRI) with diffusion-weig...
Positron emission tomography with 2-deoxy-2-fluoro-D-glucose integrated with computed tomography (FD...
Imaging of lymphoma is based on the use of18F-fluorodeoxyglucose positron emission tomography/comput...
Objectives To compare whole body-MRI (WB-MRI) with diffusion-weighted imaging and FDG-PET/CT in stag...
Since the mid-1990s, F-18-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination ...
The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance im...
Since the mid-1990s, F-18-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination ...
DOI
Add to ORKG